29 Feb 2024 Research

Nurse who made throwaway comment before blood cancer diagnosis welcomes new research boost into ‘Natural Killer’ cells

A former nurse, midwife, health visitor and NHS manager is welcoming new research into her particular blood cancer, after not recognising her mystery symptoms were leukaemia. 

Kay Cutting, from Seaham in County Durham, hopes that charity Leukaemia UK’s new project at Southampton University will help others diagnosed with chronic lymphocytic leukaemia (CLL) 

Unexplained bruising and tiredness were the first symptoms Kay began to experience in 2021.  

My second husband Alan and I were on honeymoon in Madeira when he noticed bruises which I’d not had earlier in the day,” said Kay, 62. “Alan said: “What on earth have you done to your leg?”. My entire left thigh was covered in small purple bruises and there was no explanation whatsoever for them. I remember saying: “I’ve got leukaemia or something, haven’t I?”.   

“At the time I think this was a bit of a throwaway remark, although I knew the bruising was unusual, and I knew bruising and tiredness are two symptoms of leukaemia. I had intended to go to the GP when I got home, but we were just coming out of Covid and it was still difficult to get an appointment at the time. I didn’t think the GP would take it seriously – so I let it drift.” 

Kay eventually went to her doctor when she started to have severe chronic headaches. A blood test resulted in an urgent referral to hospital and a diagnosis of chronic lymphocytic leukaemia (CLL). 

CLL is a type of blood cancer which develops slowly. It affected the lymphocytes – white blood cells in the bone marrow. It is the most common leukaemia diagnosed in adults. 38% of leukaemia cases in the UK every year are CLL – over 3800 people. 40% of them are aged 75 and over. Many people have no symptoms and receive their diagnosis after a blood test for another condition.  

Dr Matthew Blunt from the University of Southampton, has been awarded almost a quarter of a million pounds through Leukaemia UK’s Follow-up Fund for research hoping to advance treatment for CLL. His research focuses on an emerging type of immunotherapy, which harnesses the power of immune cells called ‘natural killers’.  

Natural Killer (NK) immunotherapies are already showing promise in clinical trials and importantly, are not associated with the severe toxicities that can be associated with current T-cell based treatments.  

Dr Blunt and his research team will specifically investigate lymph nodes and the environment surrounding them. Lymph nodes are already known to be critical for cancer cell survival, growth and drug resistance. The project will use cutting-edge techniques to uncover how cancer cells within the lymph nodes become resistant to NK therapies and crucially, how to overcome this.  

Dr Matt Blunt said: “This project will allow for more effective immunotherapies capable of targeting CLL cells within the protective environment of the lymph nodes. Using the immune system to fight cancer has the potential to eradicate CLL cells whilst sparing healthy cells, therefore offering a safer approach for patients.”  

“I didn’t need any treatment and was placed on ‘watch and wait’ which means I have regular reviews, and I was given a hotline to the clinic if I was worried about anything,” said Kay. 

18,000 people in the UK with CLL are currently on ‘watch and wait’*, like Kay. She continues to work as a nurse, and currently visits hospital every six months for blood tests, an examination for any swollen lymph nodes, and palpation of her liver and spleen to check if they’re enlarged.  She also agreed to take part in a separate five-year research programme into CLL and is also keen to support the work of research charity Leukaemia UK. 

“I wanted to do this because ongoing research can lead to developments in understanding disease progression and treatment options which will hopefully help other people. My hope is that I will remain stable for the rest of my natural life staying on watch and wait. I want to see my grandchildren grow up and get married, and maybe be lucky enough to meet my great grandchildren.  

“I would advise others that if they have signs no matter how small, such as fatigue, night sweats, weight loss, or unusual bruising, then don’t hesitate to see your GP and insist on a blood test.” 

Dr Simon Ridley, Director of Research and Advocacy with Leukaemia UK, said: “Breakthroughs in research have the power to discover kinder and more effective treatment options for leukaemia, and give hope to people like Kay who are living with the disease.” 

Find out more about Dr Blunt’s Follow-up Fund project.

Related posts

Leukaemia UK announces four pioneering projects into one of the deadliest forms of cancer

17 October 2023

Leukaemia UK announces four pioneering projects into one of the deadliest forms of cancer

Applications for the 2024 John Goldman Fellowships will open on 01 December 2023. The deadline for applications is 12 noon on 31 January 2024. Find out more and apply.   Leukaemia UK…

Leukaemia UK launches new Patient Care Pioneer Award funding initiative

19 February 2024

Leukaemia UK launches new Patient Care Pioneer Award funding initiative

Leukaemia UK is delighted to launch a brand-new funding scheme in 2024, intended specifically for innovative, patient-focussed applied research and targeting UK-based healthcare professionals.   The first of its kind for…

“Henry’s death cannot have been for nothing” says bereaved Mum as charities fund new research into devastating infant leukaemia

31 August 2023

“Henry’s death cannot have been for nothing” says bereaved Mum as charities fund new research into devastating infant leukaemia

Callan Brett, a mother-of-two from Ipswich, has welcomed news of a pioneering new research project into infant leukaemia; having lost her youngest son to the rare form of blood cancer…

Emerging leaders accolade for former Leukaemia UK John Goldman Fellows

20 October 2023

Emerging leaders accolade for former Leukaemia UK John Goldman Fellows

Former Leukaemia UK John Goldman Fellows, Dr Matthew Blunt, University of Southampton and Dr Konstantinos Tzelepis, University of Cambridge have been recognised as ‘Emerging Leaders in Leukaemia’ by the major…